Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality

Deirdre E.J. Anderson, Avi Gupta, Monica Hinds

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

An important consideration in the design of cardiovascular biomaterials is the prevention of thrombus formation when exposed to blood. Thrombus formation is initiated by the activation of coagulation factor XII (FXII) to FXIIa leading to thrombin formation and activation of platelets. Thrombi formed under blood flow are complex structures of blood coagulation factors, cellular components, and fibrin fibers. In the case of vascular grafts, thrombi invade the graft lumen and reduce blood flow. For many decades, thrombosis has been assessed using a chronic arteriovenous shunt implant in a non-human primate model. It has been used to study novel and clinically approved medications, novel and clinically-used vascular devices, and combinations of medications and devices. With this established technique data is collected to quantify platelet accumulation over time as well as endpoint fibrin accumulation. While this provides a reliable and quantifiable metric for assessing thrombus formation, it does little to elucidate the physical characteristics of the thrombus including size and feature morphology. This information would be particularly useful when evaluating new biomaterials designed to inhibit thrombus formation. To better assess thrombus structure, we have developed a technique using microCT to quantify luminal volume of a variety of vascular graft biomaterials. Additionally, we correlated luminal volume to platelet and fibrin quantities to allow translation of this work to broader applications.

Original languageEnglish (US)
Title of host publicationSociety for Biomaterials Annual Meeting and Exposition 2019
Subtitle of host publicationThe Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting
PublisherSociety for Biomaterials
Number of pages1
ISBN (Electronic)9781510883901
StatePublished - Jan 1 2019
Event42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Seattle, United States
Duration: Apr 3 2019Apr 6 2019

Publication series

NameTransactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium
Volume40
ISSN (Print)1526-7547

Conference

Conference42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence
CountryUnited States
CitySeattle
Period4/3/194/6/19

Fingerprint

X-Ray Microtomography
Biocompatible Materials
Platelets
Fibrin
Grafts
Blood Vessels
Thrombosis
Blood
Biomaterials
Transplants
Coagulation
Chemical activation
Factor XII
Blood Coagulation Factors
Thrombin
Fibers
Blood Platelets
Equipment and Supplies
Platelet Activation
Primates

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Biotechnology
  • Biomaterials
  • Materials Chemistry

Cite this

Anderson, D. E. J., Gupta, A., & Hinds, M. (2019). Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality. In Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium; Vol. 40). Society for Biomaterials.

Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality. / Anderson, Deirdre E.J.; Gupta, Avi; Hinds, Monica.

Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Society for Biomaterials, 2019. (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium; Vol. 40).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Anderson, DEJ, Gupta, A & Hinds, M 2019, Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality. in Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium, vol. 40, Society for Biomaterials, 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence, Seattle, United States, 4/3/19.
Anderson DEJ, Gupta A, Hinds M. Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality. In Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Society for Biomaterials. 2019. (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium).
Anderson, Deirdre E.J. ; Gupta, Avi ; Hinds, Monica. / Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality. Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Society for Biomaterials, 2019. (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium).
@inproceedings{9fdb84dbdb134eddb2cfb02b78d0fba0,
title = "Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality",
abstract = "An important consideration in the design of cardiovascular biomaterials is the prevention of thrombus formation when exposed to blood. Thrombus formation is initiated by the activation of coagulation factor XII (FXII) to FXIIa leading to thrombin formation and activation of platelets. Thrombi formed under blood flow are complex structures of blood coagulation factors, cellular components, and fibrin fibers. In the case of vascular grafts, thrombi invade the graft lumen and reduce blood flow. For many decades, thrombosis has been assessed using a chronic arteriovenous shunt implant in a non-human primate model. It has been used to study novel and clinically approved medications, novel and clinically-used vascular devices, and combinations of medications and devices. With this established technique data is collected to quantify platelet accumulation over time as well as endpoint fibrin accumulation. While this provides a reliable and quantifiable metric for assessing thrombus formation, it does little to elucidate the physical characteristics of the thrombus including size and feature morphology. This information would be particularly useful when evaluating new biomaterials designed to inhibit thrombus formation. To better assess thrombus structure, we have developed a technique using microCT to quantify luminal volume of a variety of vascular graft biomaterials. Additionally, we correlated luminal volume to platelet and fibrin quantities to allow translation of this work to broader applications.",
author = "Anderson, {Deirdre E.J.} and Avi Gupta and Monica Hinds",
year = "2019",
month = "1",
day = "1",
language = "English (US)",
series = "Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium",
publisher = "Society for Biomaterials",
booktitle = "Society for Biomaterials Annual Meeting and Exposition 2019",

}

TY - GEN

T1 - Correlating thrombus constituents of surface-modified vascular graft materials to luminal volume using microct to better quantify clinical functionality

AU - Anderson, Deirdre E.J.

AU - Gupta, Avi

AU - Hinds, Monica

PY - 2019/1/1

Y1 - 2019/1/1

N2 - An important consideration in the design of cardiovascular biomaterials is the prevention of thrombus formation when exposed to blood. Thrombus formation is initiated by the activation of coagulation factor XII (FXII) to FXIIa leading to thrombin formation and activation of platelets. Thrombi formed under blood flow are complex structures of blood coagulation factors, cellular components, and fibrin fibers. In the case of vascular grafts, thrombi invade the graft lumen and reduce blood flow. For many decades, thrombosis has been assessed using a chronic arteriovenous shunt implant in a non-human primate model. It has been used to study novel and clinically approved medications, novel and clinically-used vascular devices, and combinations of medications and devices. With this established technique data is collected to quantify platelet accumulation over time as well as endpoint fibrin accumulation. While this provides a reliable and quantifiable metric for assessing thrombus formation, it does little to elucidate the physical characteristics of the thrombus including size and feature morphology. This information would be particularly useful when evaluating new biomaterials designed to inhibit thrombus formation. To better assess thrombus structure, we have developed a technique using microCT to quantify luminal volume of a variety of vascular graft biomaterials. Additionally, we correlated luminal volume to platelet and fibrin quantities to allow translation of this work to broader applications.

AB - An important consideration in the design of cardiovascular biomaterials is the prevention of thrombus formation when exposed to blood. Thrombus formation is initiated by the activation of coagulation factor XII (FXII) to FXIIa leading to thrombin formation and activation of platelets. Thrombi formed under blood flow are complex structures of blood coagulation factors, cellular components, and fibrin fibers. In the case of vascular grafts, thrombi invade the graft lumen and reduce blood flow. For many decades, thrombosis has been assessed using a chronic arteriovenous shunt implant in a non-human primate model. It has been used to study novel and clinically approved medications, novel and clinically-used vascular devices, and combinations of medications and devices. With this established technique data is collected to quantify platelet accumulation over time as well as endpoint fibrin accumulation. While this provides a reliable and quantifiable metric for assessing thrombus formation, it does little to elucidate the physical characteristics of the thrombus including size and feature morphology. This information would be particularly useful when evaluating new biomaterials designed to inhibit thrombus formation. To better assess thrombus structure, we have developed a technique using microCT to quantify luminal volume of a variety of vascular graft biomaterials. Additionally, we correlated luminal volume to platelet and fibrin quantities to allow translation of this work to broader applications.

UR - http://www.scopus.com/inward/record.url?scp=85065439831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065439831&partnerID=8YFLogxK

M3 - Conference contribution

T3 - Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium

BT - Society for Biomaterials Annual Meeting and Exposition 2019

PB - Society for Biomaterials

ER -